BoucherH.W., TalbotG.H., BradleyJ.S.Bad bugs, no drugs: No ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis.2009; 48(1): 1–12.
2.
PogueJ.M., MannT., BarberK.E., KayeK.S.Carbapenemresistant Acinetobacter baumannii: Epidemiology, surveillance and management. Expert Rev Anti Infect Ther.2013; 11(4): 383–393.
3.
BoucherH.W., TalbotG.H., BenjaminD.K.Jr,10 × 20 progress. Development of new drugs active against gram-negative bacilli: An update from the Infectious Diseases Society of America. Clin Infect Dis.2013; 56(12): 1685–1694.
4.
CohenS.H., GerdingD.N., JohnsonS.Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol.2010; 31(5): 431–455.
5.
DellitT.H., OwensR.C., McGowanJ.E.Jr,Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis.2007; 44(2): 159–177.
WestonA., EpsteinL., DavidsonL.E.The impact of a Massachusetts state-sponsored educational program on antimicrobial stewardship in acute care hospitals. Infect Control Hosp Epidemiol.2013; 34(4): 437–439.
8.
TrivediK.K., RosenbergJ.The state of antimicrobial stewardship programs in California. Infect Control Hosp Epidemiol.2013; 34(4): 479–484.
9.
PedersenC.A., SchneiderP.J., ScheckelhoffD.J.ASHP national survey of pharmacy practice in hospital settings: Prescribing and transcribing – 2013. Am J Health Syst Pharm.2014; 71(11): 924–942.